NuTech Group

NuTech is a biologics company specializing in the development and commercialization of birth tissue-derived products for the wound care and surgical markets. The company's portfolio includes advanced allografts derived from amniotic membrane and umbilical cord tissue, designed to promote healing in chronic wounds and orthopedic applications. Following its acquisition by Organogenesis in 2017, NuTech's technology has been integrated into a broader regenerative medicine portfolio. Its products leverage the natural regenerative properties of human placental tissues to provide scaffolds and growth factors for tissue repair. The company is recognized for its proprietary processing methods that maintain the biological integrity of the tissue.